迷途知返，回头是岸！ Statement by The Lancet COVID-19 Commission - June 22, 2021 The Lancet COVID-19 Commission will carefully scrutinize the origin of the SARS-CoV-2 virus in advance of its final report, with the overriding aim of recommending policies to prevent and contain future emerging infectious disease outbreaks. The Commission’s technical work will be conducted by independent experts who were not themselves directly involved in US-China research activities that are under scrutiny. Dr. Peter Daszak has recused himself from the Commission’s work on the origins of the virus. The Commission urges all scientists who were involved in the US-China research to explain fully and transparently the nature of their work. In the meantime, the Commission will tap global experts in biosafety and other fields to help assess the relevant hypotheses on the origins of SARS-CoV-2, and to recommend ways to prevent and contain future outbreaks, whether from naturally occurring zoonotic events or research-related activities. Contact: [email protected]
回复 1楼Shang_Ri_La的帖子 柳叶刀昨天发表关于20年2月文章的补注，要求所有作者厘清利害关系。 看看那个Daszak 如何回避他与武毒所的关系。 In February, 2020, 27 public health experts co-authored a Correspondence inThe Lancet(“Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19”),1 supporting health professionals and physicians in China during the early stages of the COVID-19 pandemic. In this letter, the authors declared no competing interests. Some readers have questioned the validity of this disclosure, particularly as it relates to one of the authors, Peter Daszak. In line with guidance from the International Committee of Medical Journal Editors, medical journals ask authors to report financial and non-financial relationships that may be relevant to interpreting the content of their manuscript.2 There may be differences in opinion as to what constitutes a competing interest. Transparent reporting allows readers to make judgments about these interests. Readers, in turn, have their own interests that could influence their evaluation of the work in question. With these facts in mind, The Lancet invited the 27 authors of the letter to re-evaluate their competing interests. Peter Daszak has expanded on his disclosure statements for three pieces relating to COVID-19 that he co-authored or contributed to in The Lancet—the February, 2020, Correspondence,1 as well as a Commission Statement3 and a Comment4 for the Lancet COVID-19 Commission. The updated disclosure statement from Peter Daszak is: “PD's remuneration is paid solely in the form of a salary from EcoHealth Alliance, a 501(c)(3) non-profit organisation. EcoHealth Alliance's mission is to develop science-based solutions to prevent pandemics and promote conservation. Funding for this work comes from a range of US Government funding agencies and non-governmental sources. All past and current funders are listed publicly, and full financial accounts are filed annually and published. EcoHealth Alliance's work in China was previously funded by the US National Institutes of Health (NIH) and the United States Agency for International Development (USAID). Neither PD nor EcoHealth Alliance have received funding from the People's Republic of China. PD joined the WHO–China joint global study on the animal origins of SARS-CoV-2 towards the end of 2020 and is currently a member. As per WHO rules, this work is undertaken as an independent expert in a private capacity, not as an EcoHealth Alliance staff member. The work conducted by this study was published in March, 2021. EcoHealth Alliance's work in China includes collaboration with a range of universities and governmental health and environmental science organisations, all of which are listed in prior publications, three of which received funding from US federal agencies as part of EcoHealth Alliance grants or cooperative agreements, as publicly reported by NIH. EcoHealth Alliance's work in China is currently unfunded. All federally funded subcontractees are assessed and approved by the respective US federal agencies in advance and all funding sources are acknowledged in scientific publications as appropriate. EcoHealth Alliance's work in China involves assessing the risk of viral spillover across the wildlife–livestock–human interface, and includes behavioural and serological surveys of people, and ecological and virological analyses of animals. This work includes the identification of viral sequences in bat samples, and has resulted in the isolation of three bat SARS-related coronaviruses that are now used as reagents to test therapeutics and vaccines. It also includes the production of a small number of recombinant bat coronaviruses to analyse cell entry and other characteristics of bat coronaviruses for which only the genetic sequences are available. NIH reviewed the planned recombinant virus work and deemed it does not meet the criteria that would warrant further specific review by its Potential Pandemic Pathogen Care and Oversight (P3CO) committee. All of EcoHealth Alliance's work is reviewed and approved by appropriate research ethics committees, Institutional Animal Care and Use Committee, Institutional Review Boards for biomedical research involving human subjects, P3CO oversight administrators, and biosafety committees, as listed on all relevant publications.”
回复 10楼noshock的帖子 Transparent reporting allows readers to make judgments about these interests. Readers, in turn, have their own interests that could influence their evaluation of the work in question. 这才是正确的态度
迷途知返，回头是岸！ Statement by The Lancet COVID-19 Commission - June 22, 2021 The Lancet COVID-19 Commission will carefully scrutinize the origin of the SARS-CoV-2 virus in advance of its final report, with the overriding aim of recommending policies to prevent and contain future emerging infectious disease outbreaks. The Commission’s technical work will be conducted by independent experts who were not themselves directly involved in US-China research activities that are under scrutiny. Dr. Peter Daszak has recused himself from the Commission’s work on the origins of the virus. The Commission urges all scientists who were involved in the US-China research to explain fully and transparently the nature of their work. In the meantime, the Commission will tap global experts in biosafety and other fields to help assess the relevant hypotheses on the origins of SARS-CoV-2, and to recommend ways to prevent and contain future outbreaks, whether from naturally occurring zoonotic events or research-related activities. Contact: [email protected] Shang_Ri_La 发表于 2021-06-22 09:44
Statement by The Lancet COVID-19 Commission - June 22, 2021
The Lancet COVID-19 Commission will carefully scrutinize the origin of the SARS-CoV-2 virus in advance of its final report, with the overriding aim of recommending policies to prevent and contain future emerging infectious disease outbreaks. The Commission’s technical work will be conducted by independent experts who were not themselves directly involved in US-China research activities that are under scrutiny. Dr. Peter Daszak has recused himself from the Commission’s work on the origins of the virus.
The Commission urges all scientists who were involved in the US-China research to explain fully and transparently the nature of their work. In the meantime, the Commission will tap global experts in biosafety and other fields to help assess the relevant hypotheses on the origins of SARS-CoV-2, and to recommend ways to prevent and contain future outbreaks, whether from naturally occurring zoonotic events or research-related activities. Contact: [email protected]
================================ https://news.sina.com.cn/c/2021-06-22/doc-ikqciyzk1141877.shtml 赵立坚表示，在溯源问题上，美方没有资格对中方进行讹诈和胁迫，也没有权利代表国际社会对中国进行攻击抹黑。中方已经多次表明在溯源问题上的立场，昨天我也就此做了详细阐述，中方郑重呼吁应对美方开展三个彻底调查：一是彻底调查美国疫情源头；二是彻底调查美国抗疫不力的原因和责任者；三是彻底调查德特里克堡及200多个美国海外生物试验基地存在的问题。我们也呼吁国际社会共同努力，敦促美国配合调查，提供透明的数据和渠道。
柳叶刀昨天发表关于20年2月文章的补注，要求所有作者厘清利害关系。 看看那个Daszak 如何回避他与武毒所的关系。
In February, 2020, 27 public health experts co-authored a Correspondence inThe Lancet(“Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19”),1 supporting health professionals and physicians in China during the early stages of the COVID-19 pandemic. In this letter, the authors declared no competing interests. Some readers have questioned the validity of this disclosure, particularly as it relates to one of the authors, Peter Daszak. In line with guidance from the International Committee of Medical Journal Editors, medical journals ask authors to report financial and non-financial relationships that may be relevant to interpreting the content of their manuscript.2 There may be differences in opinion as to what constitutes a competing interest. Transparent reporting allows readers to make judgments about these interests. Readers, in turn, have their own interests that could influence their evaluation of the work in question. With these facts in mind, The Lancet invited the 27 authors of the letter to re-evaluate their competing interests. Peter Daszak has expanded on his disclosure statements for three pieces relating to COVID-19 that he co-authored or contributed to in The Lancet—the February, 2020, Correspondence,1 as well as a Commission Statement3 and a Comment4 for the Lancet COVID-19 Commission. The updated disclosure statement from Peter Daszak is: “PD's remuneration is paid solely in the form of a salary from EcoHealth Alliance, a 501(c)(3) non-profit organisation. EcoHealth Alliance's mission is to develop science-based solutions to prevent pandemics and promote conservation. Funding for this work comes from a range of US Government funding agencies and non-governmental sources. All past and current funders are listed publicly, and full financial accounts are filed annually and published. EcoHealth Alliance's work in China was previously funded by the US National Institutes of Health (NIH) and the United States Agency for International Development (USAID). Neither PD nor EcoHealth Alliance have received funding from the People's Republic of China. PD joined the WHO–China joint global study on the animal origins of SARS-CoV-2 towards the end of 2020 and is currently a member. As per WHO rules, this work is undertaken as an independent expert in a private capacity, not as an EcoHealth Alliance staff member. The work conducted by this study was published in March, 2021. EcoHealth Alliance's work in China includes collaboration with a range of universities and governmental health and environmental science organisations, all of which are listed in prior publications, three of which received funding from US federal agencies as part of EcoHealth Alliance grants or cooperative agreements, as publicly reported by NIH. EcoHealth Alliance's work in China is currently unfunded. All federally funded subcontractees are assessed and approved by the respective US federal agencies in advance and all funding sources are acknowledged in scientific publications as appropriate. EcoHealth Alliance's work in China involves assessing the risk of viral spillover across the wildlife–livestock–human interface, and includes behavioural and serological surveys of people, and ecological and virological analyses of animals. This work includes the identification of viral sequences in bat samples, and has resulted in the isolation of three bat SARS-related coronaviruses that are now used as reagents to test therapeutics and vaccines. It also includes the production of a small number of recombinant bat coronaviruses to analyse cell entry and other characteristics of bat coronaviruses for which only the genetic sequences are available. NIH reviewed the planned recombinant virus work and deemed it does not meet the criteria that would warrant further specific review by its Potential Pandemic Pathogen Care and Oversight (P3CO) committee. All of EcoHealth Alliance's work is reviewed and approved by appropriate research ethics committees, Institutional Animal Care and Use Committee, Institutional Review Boards for biomedical research involving human subjects, P3CO oversight administrators, and biosafety committees, as listed on all relevant publications.”
赵立奸需要引进这样的人才
关键词 Fauci Daszak ‘gain-of-function’ research 病毒溯源
“讹诈和胁迫“ 还好，听出来美国人不是随便说说，一笑了之了
建立国际共识之后 对付一个流氓政权有的是手段
最不济，躲开（孤立）你！
就是Daszak牵头搞的，现在总算回过味来了。。。
Transparent reporting allows readers to make judgments about these interests. Readers, in turn, have their own interests that could influence their evaluation of the work in question.
这才是正确的态度
若想人不知，除非己莫为
凡事过，总有痕迹，更别说起初的张皇失措留下的窟窿破绽，已经是覆水难收
对这号人，这就是最好的揭露
要给改过自新的机会
哈哈
你们这些给解释一下 到底是哪里来的
不过现在看起来很难 光从舆论走向看 两边都有牵扯不清的关系在里面
我被带了这个帽子几次，到现在也不知道什么意思，就当他一个123 🎵。
👌
推测柳叶刀杂志这轮风波后将沦为三流杂志，除非马上把主编和编辑们换掉。
其实都一样 谁给钱谁就是爹
怎么到你这里满世界都是轮子之类的？ 仅仅开帽子铺是不够的，说实在你连一个轮子的真凭实据也没有。有理说理有什么不好。
Gain-of-function research
美国（法国）资金、技术 中国制造
很多顶级杂志要么被渗透，要么被拉拢腐蚀
但是，数百万生命的葬送，希望能够唤醒一些人的良知和勇气
这是文明与野蛮的对决
坐等福奇老头为他的所做所为付出代价。希望快点，他都80了，万一哪天挂了就便宜他了！
经典
这次真是刷新了很多认识，连科学界和本该最注重事实最纯粹的科学家都腐败了，心痛。
61398當初錢有花在刀口上
commission 可以是委員會 也可以是
佣金
之前納札克 是委員會的一員 現在發覺 有利益衝突 也就是有收了 佣金 英文真是太奧妙了
菁英本來就這樣啊
你好我好
識大體